Nordea Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-884,642
Closed -$1.01M 886
2025
Q1
$1.01M Buy
884,642
+367,457
+71% +$564K ﹤0.01% 809
2024
Q4
$915K Buy
517,185
+91,559
+22% +$179K ﹤0.01% 818
2024
Q3
$747K Sell
425,626
-6,711
-2% -$11K ﹤0.01% 848
2024
Q2
$594K Buy
432,337
+218,182
+102% +$441K ﹤0.01% 866
2024
Q1
$815K Buy
214,155
+71,398
+50% +$418K ﹤0.01% 851
2023
Q4
$1.41M Sell
142,757
-6,374
-4% -$52.1K ﹤0.01% 762
2023
Q3
$1.25M Buy
149,131
+40,667
+37% +$465K ﹤0.01% 771
2023
Q2
$1.5M Sell
108,464
-26,952
-20% -$328K ﹤0.01% 739
2023
Q1
$1.45M Buy
+135,416
New +$1.35M ﹤0.01% 719

Other funds holding PACB